Literature DB >> 19560105

Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?

Kie Honjo1, Robert van Reekum, Nicolaas P L G Verhoeff.   

Abstract

Infection with several important pathogens could constitute risk factors for cognitive impairment, dementia, and Alzheimer's disease (AD) in particular. This review summarizes the data related to infectious agents that appear to have a relationship with AD. Infections with herpes simplex virus type 1, picornavirus, Borna disease virus, Chlamydia pneumoniae, Helicobacter pylori, and spirochete were reported to contribute to the pathophysiology of AD or to cognitive changes. Based on these reports, it may be hypothesized that central nervous system or systemic infections may contribute to the pathogenesis or pathophysiology of AD, and chronic infection with several pathogens should be considered a risk factor for sporadic AD. If this hypothesis holds true, early intervention against infection may delay or even prevent the future development of AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560105     DOI: 10.1016/j.jalz.2008.12.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  67 in total

Review 1.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

Review 2.  The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.

Authors:  Marina A Lynch
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 3.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

Review 4.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

5.  Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.

Authors:  Jan Jessen Krut; Henrik Zetterberg; Kaj Blennow; Paola Cinque; Lars Hagberg; Richard W Price; Marie Studahl; Magnus Gisslén
Journal:  J Neurol       Date:  2012-10-09       Impact factor: 4.849

Review 6.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

7.  Infectious burden and cognitive function: the Northern Manhattan Study.

Authors:  Mira Katan; Yeseon Park Moon; Myunghee Cho Paik; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  Neurology       Date:  2013-03-26       Impact factor: 9.910

8.  First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.

Authors:  Li Zhou; Eve Diefenbach; Ben Crossett; Sieu L Tran; Thomas Ng; Helen Rizos; Rejane Rua; Bin Wang; Amit Kapur; Kaushal Gandhi; Bruce J Brew; Nitin K Saksena
Journal:  Mol Neurodegener       Date:  2010-06-24       Impact factor: 14.195

9.  HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Authors:  Elaine L Bearer
Journal:  Future Virol       Date:  2012-09       Impact factor: 1.831

Review 10.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.